5.500
−5,17%
2026-10-16
Fundamental Analysis
70 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +125.2% | +140.1% | 3 / 3 | -13.3% | +1.02 pp | +3.57 pp | +1.9% | 0.20 | 21.28 | 54,5 | −13,3% | 0,4 | +125,2% | 21.28 | 23.76 | −10,4% |
| Pts | 12 | 12 | 12 | 0 | 8 | 12 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 5.500 (close price on 2026-10-16)EPS (TTM): 258,4
Financial charts
1.Revenue & growth
VND bn54,5Q2/26
1.Revenue & growth
VND bn54,5Q2/26
2.Profit & growth
VND bn0,44Q2/26
3.Profit mix (Penman)
VND bn8,60Q2/26
4.Margins & cost structure
%6.1%Q2/26
5.Returns & cash cycle
% · days0.5%Q2/26
6.Earnings quality & cash
VND bn-9,91Q2/26
7.Asset structure
VND bn360Q2/26
8.Funding & debt health
VND bn · times360Q2/26
9.Revenue backlog
VND bn0,01Q2/26
10.Valuation
times · %21,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %22Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
37.0%
averaged over 1 quarter(s)
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26